A supplement inhalation and hydrogen inhalation device for enabling supplement inhalation administration and hydrogen inhalation includes: an electrolysis tank in which a pair of positive/negative electrodes are inserted, electrolysis tank being capable of storing an electrolytic solution or water, the pair of positive/negative electrodes being either energized or not energized; a supplement generation cartridge configured to be energized to be heated for releasing a supplement-containing gas; control means configured to control the pair of electrodes and/or the supplement generation cartridge each to be either energized or not energized; and an inhalation vessel configured to mix hydrogen and a supplement-containing gas and guide the gases to an oral inhalation opening or a nasal inhalation opening.

A supplement inhalation and hydrogen inhalation device for enabling supplement inhalation administration and hydrogen inhalation includes: an electrolysis tank in which a pair of positive/negative electrodes are inserted, electrolysis tank being capable of storing an electrolytic solution or water, the pair of positive/negative electrodes being either energized or not energized; a supplement generation cartridge configured to be energized to be heated for releasing a supplement-containing gas; control means configured to control the pair of electrodes and/or the supplement generation cartridge each to be either energized or not energized; and an inhalation vessel configured to mix hydrogen and a supplement-containing gas and guide the gases to an oral inhalation opening or a nasal inhalation opening.

A system for noise and vibration management of a smoke evacuation system includes a pump that compresses air and produces a pressure differential within an airflow path. The pump may be a sealed, positive displacement pump. The system includes vibration absorption mechanisms disposed between inner and outer housings, as well as on the outside surface of the outer housing. Methods of controlling and regulating a motor of the system to preserve the lifespan of the motor and maintain consistent airflow rates throughout the smoke evacuation system include varying a supply of electrical current to the motor so that it can operate at variable performance levels. Orifices are opened and closed in order to relieve resistance pressures within the airflow path due to clogging and blockages.

The invention relates to an inhalable gaseous medicament containing argon gas for use in combination with a mechanical thrombectomy for treating, reducing or resorbing brain lesions subsequent to an ischaemic stroke in an individual. Preferably, the proportion by volume of argon is between 30 and 79%. The mechanical thrombectomy can be accompanied by a drug-based thrombolysis to dissolve the clot and to thin the blood of the patient.

Systems and methods according to present principles meet the needs of the above in several ways, and in particular provide a product that can continuously monitor and remove air from the stomach without removing liquid from a premature neonate's stomach. The device works by providing suction pressure of, e.g., 10±0.1 mmHg through the feeding tube to continuously remove air from the stomach. In this way the device prevents the problem of gastric distension all together. The pressure may be regulated by using an electronic control valve.

Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.

The present disclosure is directed to an insufflator which includes a controller, an insufflation line, a desufflation line, and one pressure sensor and one volume flow sensor associated with each of the insufflation and desufflation lines. The insufflation line is in fluid communication with a gas source and the desufflation line in fluid communication with a suction pump. Wherein the controller controls ventilation of a gas present in patient by adjusting an amount of suction in the desufflation line as a function of pressure measurements obtained from the pressure sensors associated with the insufflation and desufflation lines. Additionally, the controller includes an activation blocking system that prevents suction in the desufflation line when a pressure measured by means of the pressure sensor associated with the insufflation line is lower than a preset threshold value. Still further, the activation blocking system further prevents suction in the desufflation line when the pressure measured by means of the pressure sensor associated with the insufflation line and a pressure measured by means of the pressure sensor associated with the desufflation line are not identical.

The present disclosure is directed to an insufflator which includes a controller, an insufflation line, a desufflation line, and one pressure sensor and one volume flow sensor associated with each of the insufflation and desufflation lines. The insufflation line is in fluid communication with a gas source and the desufflation line in fluid communication with a suction pump. Wherein the controller controls ventilation of a gas present in patient by adjusting an amount of suction in the desufflation line as a function of pressure measurements obtained from the pressure sensors associated with the insufflation and desufflation lines. Additionally, the controller includes an activation blocking system that prevents suction in the desufflation line when a pressure measured by means of the pressure sensor associated with the insufflation line is lower than a preset threshold value. Still further, the activation blocking system further prevents suction in the desufflation line when the pressure measured by means of the pressure sensor associated with the insufflation line and a pressure measured by means of the pressure sensor associated with the desufflation line are not identical.

A gas mixture apparatus includes a measurement control system, an activation system, a pressurized chamber with one or more gases, and a mixing chamber. A filter can be preattached to the outlet of the mixture apparatus, allowing excess gas to be discharged therethrough and then atmospheric air to be drawn into the mixture apparatus through the filter for creating a therapeutic gas mixture.

The present disclosure is directed to methods of treating subject patients (such as humans, animals, plants) suffering from a pathogenic disease such as COVID-19 in humans, via the administration of pressure changes in the patient sufficient to cause a pressure differential to be created between the inside and outside of the outer membrane or envelope of the pathogen thereby destroying or disabling the pathogen. In one embodiment, a hyperbaric chamber is used to administer pressure increases and/or pressure decreases to create such pressure differential. The hyperbaric chamber could comprise a single user or multi-user unit, a pressurized body suit, or the pressurizable fuselage of an aircraft. In another embodiment, patients are placed in an aircraft, and the cabin pressure, while on the ground, or in flight, is adjusted upwardly or downwardly to create such pressure differential. The pressure differential methods can also include the use of external gases to enter the patient's body and/or lungs to facilitate disruption of the pathogen outer membrane as well as application of variations in temperature and/or humidity. A mobile treatment unit is also disclosed. Also disclosed are methods of using ultrasonic cavitation or MRI (or other sonic or magnetic field forces sufficient to disrupt the functionality of the pathogen), or a combination of ultrasound and MRI on the exterior of a patient in a desired anatomical region of the patient to assist with the destruction or disabling of a pathogen infecting that anatomical region of the patient, e.g., the patient's lungs, said method being employed at ambient pressures or in an increased or decreased pressure environment created within a hyperbaric chamber. The ultrasound and/or MRI methodologies could also be used to treat other pathogenically afflicted areas of the patient's body. Additionally, a pressure-differential method of sterilization of medical equipment is disclosed employing a hyperbaric or other pressure or vacuum chamber. Also disclosed is an enhanced method of nonsurgical fat reduction in humans by employing ultrasonic cavitation within a hyperbaric chamber, including the use of HBOT therapies. Furthermore, the use of these methodologies and systems have application in treatment of patients post-infection and in other areas of medicine and health, such as for example, treating wounds, the effects of aging, inflammation, and the effects of other maladies.